These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 11817528

  • 1. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass.
    De SF, Van BY, Caes F, François K, Arnout J, Bossuyt X, Taeymans Y, Van NG.
    Perfusion; 2002 Jan; 17(1):39-44. PubMed ID: 11817528
    [Abstract] [Full Text] [Related]

  • 2. Active or passive bio-coating: does it matters in extracorporeal circulation?
    Jacobs S, De Somer F, Vandenplas G, Van Belleghem Y, Taeymans Y, Van Nooten G.
    Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface.
    De Somer F, François K, van Oeveren W, Poelaert J, De Wolf D, Ebels T, Van Nooten G.
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):602-6. PubMed ID: 11053824
    [Abstract] [Full Text] [Related]

  • 4. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M, Kobayashi S, Niwaya K, Hamada Y, Kitamura S.
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [Abstract] [Full Text] [Related]

  • 5. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W.
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [Abstract] [Full Text] [Related]

  • 6. Impact of a phosphorylcholine-coated cardiac bypass circuit on blood loss and platelet function: a prospective, randomized study.
    Marguerite S, Levy F, Quessard A, Dupeyron JP, Gros C, Steib A.
    J Extra Corpor Technol; 2012 Mar; 44(1):5-9. PubMed ID: 22730857
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phosphorylcholine coating of bypass systems used for young infants does not attenuate the inflammatory response.
    Draaisma AM, Hazekamp MG, Anes N, Schoof PH, Hack CE, Sturk A, Dion RA.
    Ann Thorac Surg; 2006 Apr; 81(4):1455-9. PubMed ID: 16564292
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial.
    Paparella D, Scrascia G, Rotunno C, Marraudino N, Guida P, De Palo M, Rubino G, Cappabianca G.
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):557-62. PubMed ID: 22658688
    [Abstract] [Full Text] [Related]

  • 12. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN, Videm V, Baksaas ST, Mollnes TE, Brosstad F, Svennevig JL.
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Sohn N, Marcoux J, Mycyk T, Krahn J, Meng Q.
    Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.
    Wagner WR, Johnson PC, Thompson KA, Marrone GC.
    Ann Thorac Surg; 1994 Sep; 58(3):734-40; discussion 741. PubMed ID: 7944696
    [Abstract] [Full Text] [Related]

  • 19. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T, Osawa S, Ogawa M, Sasaki T, Izumoto H, Yagi Y, Kawazoe K.
    ASAIO J; 1996 Sep; 42(4):301-5. PubMed ID: 8828788
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.